Pre- and postoperative systemic hemodynamic evaluation in patients subjected to esophagogastric devascularization plus splenectomy and distal splenorenal shunt: A comparative study in schistomomal portal hypertension

被引:37
作者
de Cleva, Roberto [1 ]
Herman, Paulo [1 ]
Carneiro D'albuquerque, Luis Augusto [1 ]
Pugliese, Vincenzo [1 ]
Santarem, Orlando Luis [1 ]
Saad, William Abrao [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Dept Gastroenterol, BR-05403900 Sao Paulo, Brazil
关键词
pulmonary hypertension; hyperdynamic circulation; portal hypertension; splenectomy; cardiomyopathy;
D O I
10.3748/wjg.v13.i41.5471
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the systemic hemodynamic effects of two surgical procedures largely employed for treatment of schistosomal portal hypertension. METHODS: Thirty-six patients undergoing elective surgical treatment of portal hypertension due to hepatosplenic mansonic schistosomiasis were prospectively evaluated. All patients were subjected to preoperative pulmonary artery catheterization; 17 were submitted to esophagogastric clevascularization and splenectomy (EGDS) and 19 to distal splenorenal shunt (DSRS). The systemic hemodynamic assessment was repeated 4 d after the surgical procedure. RESULTS: Preoperative evaluation revealed (mean SD) an increased cardiac index (4.78 +/- 1.13 L/min per m(2)), associated with a reduction in systemic vascular resistance index (1457 +/- 380.7 dynes. s/cm(5). m(2)). The mean pulmonary artery pressure (18 +/- 5.1 mmHg) as well as the right atrial pressure (7.9 +/- 2.5 mmHg) were increased, while the pulmonary vascular resistance index (133 +/- 62 dynes.s/cm(5).m(2)) was decreased. Four days after EGDS, a significant reduction in cardiac index (3.80 +/- 0.4 L/min per m(2), p < 0.001) and increase in systemic vascular resistance index (1901.4 +/- 330.2 dynes.s/cm(5). m(2), P < 0.001) toward normal levels were observed. There was also a significant reduction in pulmonary artery pressure (12.65 +/- 4.7 mmHg, P < 0.001) and no significant changes in the pulmonary vascular resistance index (141.6 +/- 102.9 dynes. s/cm(5). m(2)). Four days after DSRS, a non-significant increase in cardiac index (5.2 +/- 0.76 L/min per m(2)) and systemic vascular resistance index (1389 +/- 311 dynes.s/cm(5). m(2)) was observed. There was also a non-significant increase in pulmonary artery pressure (19.84 +/- 5.2 mmHg), right cardiac work index (1.38 +/- 0.4 kg.m/m(2)) and right ventricular systolic work index (16.3 +/- 6.3 g.m/m(2)), without significant changes in the pulmonary vascular resistance index (139.7 +/- 67.8 dynes. S/cm(5).m(2)). CONCLUSION: The hyperdynamic circulatory state observed in mansonic schistosomiasis was corrected by EGDS, but was maintained in patients who underwent DSRS. Similarly, the elevated mean pulmonary artery pressure was corrected after EGDS and maintained after DSRS. EGDS seems to be the most physiologic surgery for patients with schistosomal portal hypertension. (C) 2007 WJG. All rights reserved.
引用
收藏
页码:5471 / 5475
页数:5
相关论文
共 25 条
[1]   Portopulmonary hypertension in decompensated cirrhosis with refractory ascites [J].
Benjaminov, FS ;
Prentice, M ;
Sniderman, KW ;
Siu, S ;
Liu, P ;
Wong, F .
GUT, 2003, 52 (09) :1355-1362
[2]   Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients [J].
Castro, M ;
Krowka, MJ ;
Schroeder, DR ;
Beck, KC ;
Plevak, DJ ;
Rettke, SR ;
Cortese, DA ;
Wiesner, RH .
MAYO CLINIC PROCEEDINGS, 1996, 71 (06) :543-551
[3]  
Cleva Roberto de, 2004, Rev. Hosp. Clin., V59, P10, DOI 10.1590/S0041-87812004000100003
[4]   Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis [J].
De, BK ;
Majumdar, D ;
Das, D ;
Biswas, PK ;
Mandal, SK ;
Ray, S ;
Bandopadhyay, K ;
Das, TK ;
Dasgupta, S ;
Guru, S .
JOURNAL OF HEPATOLOGY, 2003, 39 (03) :315-319
[5]  
de Cleva R, 1998, Rev Hosp Clin Fac Med Sao Paulo, V53, P6
[6]  
de Cleva R, 1999, AM J GASTROENTEROL, V94, P1632, DOI 10.1111/j.1572-0241.1999.01086.x
[7]  
de Cleva R, 2005, HEPATO-GASTROENTEROL, V52, P1529
[8]  
de Cleva R, 2003, HEPATO-GASTROENTEROL, V50, P2028
[9]  
de Cleva R, 1996, REV MED SAO PAULO, V75, P126
[10]  
de Cleva R, 2004, WORLD J GASTROENTERO, V10, P1836